Opinion
Civil Action No. 11-cv-01389-WJM-KLM
11-14-2011
GENETIC TECHNOLOGIES LIMITED, an Australian corporation, Plaintiff and Counter Defendant, v. AGILENT TECHNOLOGIES, INC., a Delaware corporation, BRISTOL-MYERS SQUIBB COMPANY, a Delaware corporation, EUROFINS STA LABORATORIES, INC., a Colorado corporation, MERIAL L.L.C., a Delaware limited liability company, PFIZER INC., a Delaware corporation, 454 LIFE SCIENCES CORPORATION, a Delaware corporation, GENESEEK, INC., a Nebraska corporation, and GLAXOSMITHKLINE LLC, a Delaware corporation, Defendants; BRISTOL-MYERS SQUIBB COMPANY, a Delaware corporation, and EUROFINS STA LABORATORIES, INC., a Colorado corporation, Counter Claimants.
MINUTE ORDER
ENTERED BY MAGISTRATE JUDGE KRISTEN L. MIX
This matter is before the Court on the Unopposed Motion by Pfizer Inc. for Permission to Appear by Telephone at the Rule 26(f) Scheduling Conference [Docket No. 242; Filed November 14, 2011] (the "Motion").
IT IS HEREBY ORDERED that the Motion is GRANTED. On the date and time of the conference, all counsel who have been given permission to appear by telephone shall arrange a conference call and contact the Court on a single line at (303) 335-2770 to participate.